, a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. This would suggest that RAPT Therapeutics's shares are less volatile than average (for this exchange). The market (NASDAQ average) beta is 1, while RAPT Therapeutics's is 0.1262. A popular way to gauge a stock's volatility is its "beta".īeta is a measure of a share's volatility in relation to the market. Over the last 12 months, RAPT Therapeutics's shares have ranged in value from as little as $14.89 up to $43.26. We're not expecting RAPT Therapeutics to pay a dividend over the next 12 months. TTM: trailing 12 months RAPT Therapeutics share dividends We chose Tradier for this because it offers a wealth of tools and data for active traders, including the ability to use its data and create a custom trading platform. You can search for stocks by company name, and the mobile app is clean and intuitive to use. We chose Robinhood for this category because it offers commission-free trading and is easy to use. That means you can open an active investing account to pick and choose companies you want to invest in, and open a robo-advisor account to help you build a portfolio and manage how much risk you take on. We chose SoFi for this category because it offers a free robo-advisor as well as commission-free stocks. We encourage you to compare stock platforms to find one that's best for your particular budget and goals. We evaluate stock trading platforms against a range of metrics that include fees, ease of use, available securities and advanced tools to meet specific investor needs.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |